220 mutation in the hemagglutinin of avian influenza A (H7N9) virus alters antigenicity during vaccine strain development

220 mutation in the hemagglutinin of avian influenza A (H7N9) virus alters antigenicity during vaccine strain development

Since the first confirmed case of H7N9 infection was reported in China, there have been five epidemic waves of human H7N9 infections between 2013 and 2017. The fifth wave differed from the previous four waves in that highly pathogenic avian influenza (HPAI) H7N9 viruses with multiple basic amino aci...

Full description

Bibliographic Details
Main Authors: Liqi Liu, Jian Lu, Zi Li, Jianfang Zhou, Junfeng Guo, Xiyan Li, Jia Liu, Yuelong Shu, Dayan Wang
Format: Article
Language:English
Published: Taylor & Francis Group 2018-03-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
highly pathogenic
avian influenza a (h7n9) virus
candidate vaccine virus
reverse genetics
antigenicity
Online Access:http://dx.doi.org/10.1080/21645515.2017.1419109

Similar Items

Similar Items